Gap junction-mediated intercellular communication in ischemic preconditioning

Cardiovascular Research

Volumn 55, Issue 3, 2002, Pages 456-465

  Garcia Dorado, David ^a   Ruiz Meana, Marisol ^a   Padilla, Ferran ^a   Rodriguez Sinovas, Antonio ^a   Mirabet, Maribel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Gap junctions; Infarction; Ischemia; Myocytes; Preconditioning; Reperfusion

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GAP JUNCTION PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; SYNAPTOPHYSIN;

CELL COMMUNICATION; CELL DEATH; ENZYME ACTIVATION; ENZYME ANALYSIS; GAP JUNCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; LETHALITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; REPERFUSION; REVIEW; ANIMAL; APOPTOSIS; CELL JUNCTION; HEART MUSCLE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TIME; ULTRASTRUCTURE;

ANIMAL; APOPTOSIS; CELL COMMUNICATION; GAP JUNCTIONS; HUMAN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; ANIMALS; HUMANS;

EID: 0036023615     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00441-8     Document Type: Review

References (130)

1. Ischemic preconditioning in humans. Models, mediators, and clinical relevance
2. Adenosine receptor involvement in a delayed phase of myocardial protection 24 h after ischemic preconditioning
3. Gap junction channels in the cardiovascular system: Pharmacological and physiological modulation
4. Cardiac muscle cell interaction: From microanatomy to the molecular make-up of the gap junction
5. Gap junctions in cardiovascular disease
6. The gap junction communication channel
7. Cardiac gap junction channels: Modulation of expression and channel properties
8. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes
9. The Ib phase of ventricular arrhythmias in ischemic in situ porcine heart is related to changes in cell-to-cell electrical coupling. Experimental Cardiology Group, University of North Carolina
10. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle
11. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia
12. Passive electrical properties, mechanical activity, and extracellular potassium in arterially perfused and ischemic rabbit ventricular muscle
13. Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions
14. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion
15. Ph regulation of connexin43: Molecular analysis of the gating particle
16. Connexin diversity and gap junction regulation by pHi
17. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 beta-glycyrrhetinic acid
18. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication
19. Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis
20. 2+, intercellular electrical coupling, and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade
21. Phosphatases involved in modulation of gap junctional intercellular communication and dephosphorylation of connexin43 in hamster fibroblasts: 2B or not 2B?
22. A mitosis-specific phosphorylation of the gap junction protein connexin43 in human vascular cells: Biochemical characterization and localization
23. Gating connexin 43 channels reconstituted in lipid vesicles by mitogen-activated protein kinase phosphorylation
24. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions
25. Role of PKC and MAP kinase in EGF- and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells
26. V-Src phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap junctional communication
27. Inhibition of connexin43 gap junctional intercellular communication by TPA requires ERK activation
28. Untangling the Web: Specific signaling from PKC isoforms to MAPK cascades
29. Dephosphorylation agents depress gap junctional communication between rat cardiac cells without modifying the Connexin43 phosphorylation degree
30. Immunorecognition, ultrastructure and phosphorylation status of astrocytic gap junctions and connexin43 in rat brain after cerebral focal ischaemia
31. Gap junction assembly: PTX-sensitive G proteins regulate the distribution of connexin43 within cells
32. Ischaemic preconditioning: Present position and future directions
33. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
34. The mitochondrial K ATP channel as a receptor for potassium channel openers
35. Ischemic preconditioning: From adenosine receptor to K ATP channel
36. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels
37. P38 triggers late preconditioning elicited by anisomycin in heart: Involvement of NF-kappaB and iNOS
38. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning
39. Mitochondrial K(ATP) channels: Triggers or distal effectors of ischemic or pharmacological preconditioning?
40. A fresh look at reperfusion injury
41. Ischemic preconditioning preserves creatine phosphate and intracellular pH
42. Protection of energy status of hypoxic cardiomyocytes by mild acidosis
43. The role of Na+/H+ exchange in ischemia-reperfusion
44. Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7. Implications for the protective effect of low pH against chemical and hypoxic cell damage
45. Volume regulation and plasma membrane injury in aerobic, anaerobic and ischemic myocardium in vitro
46. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode
47. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts
48. Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular ph in the rat heart
49. Differential effects of norepinephrine on contractile recovery of rat trabeculae following metabolic inhibition
50. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke
51. Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine. Implications for ischemic preconditioning
52. 2+ in single rat heart cells during anoxia and reoxygenation
53. Direct observation of the 'oxygen paradox' in single rat ventricular myocytes
54. 2+ overload
55. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart
56. Coronary cyclic flow variations 'preconditioning' ischemic myocardium
57. Preservation of myofilament calcium responsiveness underlies protection against myocardial stunning by ischemic preconditioning
58. Dissociation between anti-infarct effect and anti-edema effect of ischemic preconditioning
59. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis
60. Protective effects of preconditioning in cultured rat endothelial cells Effects of neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation
61. Effects of ischemic preconditioning on myocardial perfusion, function, and microvascular regulation
62. Na(+)/H(+) exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow
63. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H+ exchange
64. The (still) unknown mechanism of ischemic preconditioning: Possible involvement of reduced Na+/H+ exchange
65. Protective effects of HOE642,a selective sodium-hydrogen exchange subtype 1 inhibitor,on cardiac ischaemia and reperfusion
66. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells
67. Drugs preventing Na+ and Ca2+ overload
68. Time course of myocardial necrosis
69. Reperfusion of ischemic myocardium: Ultrastructural and histochemical aspects
70. Pathobiology of acute myocardial ischemia: Metabolic, functional and ultrastructural studies
71. Ultrastructural alterations during the critical phase of reperfusion: A stereological study in buffer-perfused isolated rat hearts
72. Temporal and spatial development of infarcts in porcine hearts
73. L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig
74. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs
75. Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin
76. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition and infarct geometry during
77. Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size
78. Transmural cellular damage and blood flow distribution in early ischemia in pig hearts
79. Irreversible injury of isolated adult rat myocytes. Osmotic fragility during metabolic inhibition
80. Myocardial segment shrinkage during coronary reperfusion in situ. Relation to hypercontracture and myocardial necrosis
81. L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism
82. Urodilatin limits acute reperfusion injury in the isolated rat heart
83. Oxygen delivery and consumption and P50 in patients with acute myocardial infarction
84. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition
85. Simulated ischemia increases the susceptibility of rat cardiomyocytes to hypercontracture
86. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia
87. 2+ exchanger in reoxygenation-induced cardiomyocyte injury
88. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture
89. Nitric oxide: A trigger for classic preconditioning?
90. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury
91. Astrocytic gap junctions remain open during ischemic conditions
92. Gap-junction-mediated propagation and amplification of cell injury
93. Effective reduction of neuronal death by inhibiting gap junctional intercellular communication in a rodent model of global transient cerebral ischemia
94. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation
95. Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: Effects of dibutyryl adenosine 3′,5′-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside
96. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma
97. Blockade of gap junction communication during the early period of ischemia protects cardiomyocytes from infarction
98. Cell-to-cell interaction: A mechanism to explain wave-front progression of myocardial necrosis
99. Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiac myocytes
100. Electrical constants of trabecular muscle from mammalian heart
101. Slow conduction in cardiac tissue. I: Effects of a reduction of excitability versus a reduction of electrical coupling on microconduction
102. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels
103. Persistence of gap junction communication during myocardial ischemia
104. Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart
105. Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: Complex formation as a means for cardioprotective signaling
106. Preconditioning attenuates apoptosis and necrosis: Role of protein kinase C epsilon and -delta isoforms
107. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation
108. The K-ATP channel regulates the effect of Ca+2 on gap junction permeability in cultured astrocytes
109. Preconditioning in the absence or presence of sustained ischemia modulates myocardial Cx43 protein levels and gap junction distribution
110. + exchange blockade and ischemic preconditioning
111. Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning
112. Nitric oxide-stimulated increase in intracellular cGMP modulates gap junction coupling in rat neocortex
113. Induction of nitric oxide synthase inhibits gap junction permeability in cultured rat astrocytes
114. Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP
115. Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes
116. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis
117. Ischemic preconditioning decreases apoptosis in rat hearts in vivo
118. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Role of the terminal complement components and inhibition by anti-C5 therapy
119. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
120. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
121. Early apoptosis in human myocardial infarcts
122. Apoptosis in human acute myocardial infarction
123. Influence of simulated ischemia on apoptosis induction by oxidative stress in adult cardiomyocytes of rats
124. Contribution of myocyte apoptosis to myocardial infarction?
125. Cardiac gap junctions: Good or bad?
126. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells
127. Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myocytes
128. Role of gap junctions in inhibiting ischemia-reperfusion injury of rat gastric mucosa